162 related articles for article (PubMed ID: 35118450)
1. An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report.
Shwana S; Shrikrishnapalasuriyar N; Yin W; Vij M; Kalhan A
touchREV Endocrinol; 2021 Apr; 17(1):75-78. PubMed ID: 35118450
[TBL] [Abstract][Full Text] [Related]
2. A Case of Ovarian Hyperthecosis in a Postmenopausal Woman.
Yousaf S; Nizar R; John L; Simpson A
JCEM Case Rep; 2023 Nov; 1(6):luad148. PubMed ID: 38077307
[TBL] [Abstract][Full Text] [Related]
3. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
Ferrinho C; Silva E; Oliveira M; Sequeira Duarte J
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33731391
[TBL] [Abstract][Full Text] [Related]
5. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism.
Pathmanathan S; De Silva SDN; Sumanatilleke M; Lokuhetty D; Ranathunga UVV
Case Rep Endocrinol; 2022; 2022():8804856. PubMed ID: 35190778
[TBL] [Abstract][Full Text] [Related]
6. The Use of Ovarian Vein Sampling to Lateralize a Virilizing Leydig Cell Ovarian Tumor.
Baweja K; Shuster S; Awad S
AACE Clin Case Rep; 2023; 9(6):182-185. PubMed ID: 38045790
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
8. Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman.
Chantler DJ; Gordon D; Millan D; Panarelli M
BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22696667
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal mild hirsutism and hyperandrogenemia due to ovarian Sertoli-Leydig cell tumor: A case report.
Chen D; Zhang J; Shi W; Wang XH; Zhang SW
Heliyon; 2020 Apr; 6(4):e03746. PubMed ID: 32280807
[TBL] [Abstract][Full Text] [Related]
10. Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women.
Bahaeldein E; Brassill MJ
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30481153
[TBL] [Abstract][Full Text] [Related]
11. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
[TBL] [Abstract][Full Text] [Related]
13. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
14. SEVERE HYPERANDROGENISM IN A PREMENOPAUSAL WOMAN WITH AN IMAGING-NEGATIVE LEYDIG CELL TUMOR.
Lubchansky SB; McManus R
AACE Clin Case Rep; 2020; 6(6):e290-e294. PubMed ID: 33244487
[TBL] [Abstract][Full Text] [Related]
15. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
16. MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).
Gheorghisan-Galateanu AA; Terzea D; Valea A; Carsote M
Acta Endocrinol (Buchar); 2017; 13(3):356-363. PubMed ID: 31149200
[TBL] [Abstract][Full Text] [Related]
17. Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report.
Vatopoulou A; Gkrozou F; Birbas E; Kanavos T; Skentou C; Miliaras D
Case Rep Womens Health; 2023 Sep; 39():e00537. PubMed ID: 37692362
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
[TBL] [Abstract][Full Text] [Related]
19. Pure Leydig cell tumour (hilus cell) of the ovary: a rare cause of virilization after menopause.
Baiocchi G; Manci N; Angeletti G; Celleno R; Fratini D; Gilardi G
Gynecol Obstet Invest; 1997; 44(2):141-4. PubMed ID: 9286731
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia.
O'Driscoll JB; Mamtora H; Higginson J; Pollock A; Kane J; Anderson DC
Clin Endocrinol (Oxf); 1994 Aug; 41(2):231-6. PubMed ID: 7923828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]